IFS is believed to be a useful treatment for PTSD. A new study provides the first research-based evidence of its efficacy.

Back in 2024, Renesas first released the RA0E1, an ultra-low-power Cortex-M23 MCU designed for cost-sensitive applications, followed by the RA0E2, with ...

A team of University of Michigan investigators reported that their multimodal, chronic disease self-management support program for people living with glaucoma, SEE, was linked to an approximate 20% ...

The cobot feeder includes a storage and retrieval assembly with a UR force- and power-limited robot pedestal, enclosed steel ...

The trials are evaluating DURAVYU (vorolanib intravitreal insert) for the treatment of diabetic macular edema (DME).

Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

Active Phase 3 programs for DURAVYU in wet AMD and DME, the two largest multi-billion-dollar retinal disease markets - ...

Both pivotal Phase 3 trials for DURAVYU in wet AMD on track for data readout beginning in mid-2026 - - Patients dosed in both COMO and CAPRI Phase 3 clinical trials for DURAVYU in DME - - Michael ...

On the corner of Northeast Knott Street and 33rd Avenue stands a neighborhood stalwart. It’s called Family Medical Group NE. The other day, Dave, who lives a few blocks away, stood under his blooming ...

THE CHEST IS a muscle group that takes up a great deal of attention for physique-minded guys. If you pause a moment to think about why, you won't need long to figure out the appeal of chest-pumping ...

Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS study PALYNZIQ is the ...

TD Cowen 46th Annual Health Care Conference March 3, 2026 1:50 PM ESTCompany ParticipantsJames Mock - Chief Financial ...